Viperin restricts chikungunya virus replication and pathology

Page view(s)
Checked on May 18, 2023
Viperin restricts chikungunya virus replication and pathology
Viperin restricts chikungunya virus replication and pathology
Journal Title:
Journal of Clinical Investigation
Publication Date:
19 November 2012
Teng, T.-S., Foo, S.-S., Simamarta, D., Lum, F.-M., Teo, T.-H. et al. Viperin restricts chikungunya virus replication and pathology. The Journal of Clinical Investigation 122, 4447–4460 (2012).
Chikungunya virus (CHIKV) is a mosquito-borne arthralgia arbovirus that is reemergent in sub-Saharan Africa and Southeast Asia. CHIKV infection has been shown to be self-limiting, but the molecular mechanisms of the innate immune response that control CHIKV replication remain undefined. Here, longitudinal transcriptional analyses of PBMCs from a cohort of CHIKV-infected patients revealed that type I IFNs controlled CHIKV infection via RSAD2 (which encodes viperin), an enigmatic multifunctional IFN-stimulated gene (ISG). Viperin was highly induced in monocytes, the major target cell of CHIKV in blood. Anti-CHIKV functions of viperin were dependent on its localization in the ER, and the N-terminal amphipathic α-helical domain was crucial for its antiviral activity in controlling CHIKV replication. Furthermore, mice lacking Rsad2 had higher viremia and severe joint inflammation compared with wild-type mice. Our data demonstrate that viperin is a critical antiviral host protein that controls CHIKV infection and provide a preclinical basis for the design of effective control strategies against CHIKV and other reemerging arthrogenic alphaviruses.
License type:
Funding Info:
Files uploaded: